Insider Trading July 8, 2026 04:19 PM

Appian CEO Calkins Offloads $1.24M in Shares Under Pre-Arranged Plan

Executive transaction occurs as the software firm reports strong Q1 2026 earnings, though analyst price target is revised downward.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
APPN

Appian Corp. (NASDAQ:APPN) CEO Matthew W. Calkins executed a series of stock sales totaling $1,236,243 on July 7, 2026. The transactions involved the disposition of 50,000 Class A Common Stock shares, conducted automatically through a Rule 10b5-1 trading plan established in March 2026. This executive activity follows the company's first quarter of 2026 financial results, which showed significant outperformance in both earnings and revenue metrics. Despite strong operational results, DA Davidson has adjusted its outlook on the stock, lowering its price target while maintaining a neutral rating based on the company's AI-driven revenue potential.

Appian CEO Calkins Offloads $1.24M in Shares Under Pre-Arranged Plan
APPN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Appian CEO Matthew W. Calkins sold 50,000 shares worth $1,236,243 on July 7, 2026, through a Rule 10b5-1 plan adopted in March 2026.
  • Appian reported Q1 2026 EPS of $0.27, beating forecasts by 50%, with revenue of $202.2 million, exceeding expectations by 5.44%.
  • DA Davidson lowered its price target for Appian from $25 to $22, maintaining a Neutral rating while acknowledging the company's AI revenue potential.

Matthew W. Calkins, serving as both Chief Executive Officer and President of Appian Corp. (NASDAQ:APPN), completed the sale of Class A Common Stock amounting to $1,236,243 on July 7, 2026. The executive activity comprised the disposition of 50,000 shares, executed at weighted average prices between $24.61 and $25.07 per share. These transactions were structured under a Rule 10b5-1 trading plan, which Calkins initially adopted on March 5, 2026, ensuring the sales were automatic and pre-arranged rather than spontaneous market decisions.

The July 7, 2026, liquidation occurred in two distinct phases. In the first transaction, Calkins disposed of 37,515 shares at a weighted average price of $24.61 per share, with individual share prices fluctuating between $23.87 and $24.86. The subsequent transaction involved the sale of 12,485 shares at a weighted average price of $25.07 per share, with individual prices ranging from $24.87 to $25.24. Following these dispositions, Calkins retains direct ownership of 1,719,144 shares of Appian Corp. Class A Common Stock.

The timing of these sales coincides with a period of significant price volatility for Appian shares. The sale prices align closely with the stock's current trading level of $24.27. Over the preceding six months, Appian shares have declined by 29%, reflecting broader market pressures on the software sector. Despite this depreciation, recent analysis suggests the stock may currently appear undervalued relative to its fair value estimate.

Appian Corporation recently reported financial results for the first quarter of 2026 that exceeded market expectations. The company achieved an earnings per share (EPS) of $0.27, surpassing the forecasted $0.18 by a margin of 50%. Revenue reached $202.2 million, representing a 5.44% increase over the anticipated $191.76 million. These results highlight the company's ability to generate financial momentum despite the stock's recent decline.

In response to these developments, DA Davidson adjusted its outlook on Appian, lowering the stock price target from $25 to $22 while maintaining a Neutral rating. The firm cited a more favorable view of Appian's potential to generate revenue from AI applications. Appian's platform is recognized for enabling AI solutions that provide reliable and deterministic answers for its customers, a capability that supports the firm's positive trajectory in leveraging AI technology.

Investors evaluating Appian Corp. should consider the interplay between strong operational fundamentals and executive stock activity. While the company continues to demonstrate earnings growth and revenue expansion, the recent price target adjustment by DA Davidson introduces a layer of caution regarding near-term valuation expectations. The automated nature of Calkins' sales under a pre-existing trading plan provides context for the transaction, though the broader market decline and analyst adjustments remain key factors influencing the stock's current position.

Risks

  • Appian shares have declined 29% over the past six months, indicating significant volatility and potential downward pressure on the stock price.
  • DA Davidson's adjustment of the price target from $25 to $22 suggests a more cautious outlook on near-term valuation despite strong earnings.
  • The automated nature of the CEO's sales under a Rule 10b5-1 plan limits the ability to interpret the transaction as a direct reflection of current market sentiment.

More from Insider Trading

Heartflow Executive Liquidation Precedes Stock Surge Amid Strong Quarterly Results Aug 19, 2026 Bloom Energy CCO Executes $1.13 Million Stock Disposition Amid Strong Q2 Earnings and Analyst Divergence Aug 19, 2026 Pacific Biosciences Executive Reduces Stake Amid Financial Headwinds Aug 18, 2026 Stoke Therapeutics Board Member Liquidates Equity Stake Following Restricted Unit Settlement Aug 18, 2026 Cisco Leadership Transaction Highlights Valuation Debate Amid Strong Fiscal Fourth Quarter Aug 18, 2026